Clinical trial
The Efficacy and Safety of Ainuovirine in the Treatment of HIV-infected/AIDS Patients in China
NCT05420246 is registered in ClinicalTrials.gov with Guangzhou 8th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Ainuovirine in the Treatment of HIV-infected/AIDS Patients in China
- Lead sponsor
- Guangzhou 8th People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- December 31, 2025
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv/aids